Info

TranXenoGen, Inc. is a biotechnology company focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products. Its product pipeline includes Anti-Neoplastic Urinary Protein ("ANUP") for the treatment of several types of cancer, Insulin and Human Serum Albumin ("HSA"). The Company believes that its technology platform will have multiple applications including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, and animal models for the study of disease TranXenoGen is developing its technology platform for the production of generic biologicals (e.g., Insulin and HSA), contract manufacturing of third party products and potential applications in the areas of biodefense and vaccine development. In addition, the Company is exploring licensing of both the technology and products for certain geographic areas and commercial applications.